David S Tierney - Net Worth and Insider Trading
David S Tierney Net Worth
The estimated net worth of David S Tierney is at least $5 Million dollars as of 2024-04-28. David S Tierney is the Director of Catalyst Pharmaceuticals Inc and owns about 348,874 shares of Catalyst Pharmaceuticals Inc (CPRX) stock worth over $5 Million. David S Tierney is the CEO of BioPharmX Corp and owns about 25,000 shares of BioPharmX Corp (BPMX) stock worth over $153,000. David S Tierney is also the Director of Zevra Therapeutics Inc and owns about 10,835 shares of Zevra Therapeutics Inc (ZVRA) stock worth over $48,974. Details can be seen in David S Tierney's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David S Tierney has not made any transactions after 2024-04-08 and currently still holds the listed stock(s).
Transaction Summary of David S Tierney
David S Tierney Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David S Tierney owns 5 companies in total, including Zevra Therapeutics Inc (ZVRA) , Catalyst Pharmaceuticals Inc (CPRX) , and Trex Wind Down Inc (TMBRQ) among others .
Click here to see the complete history of David S Tierney’s form 4 insider trades.
Insider Ownership Summary of David S Tierney
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZVRA | Zevra Therapeutics Inc | 2023-03-09 | director |
| CPRX | Catalyst Pharmaceuticals Inc | 2024-04-08 | director |
| TMBRQ | Trex Wind Down Inc | 2018-09-19 | director & CEO |
| BJCT | Bioject Medical Technologies Inc | 2014-04-30 | director |
| SEEL | Seelos Therapeutics Inc | 2007-01-29 | director |
David S Tierney Latest Holdings Summary
David S Tierney currently owns a total of 3 stocks. Among these stocks, David S Tierney owns 348,874 shares of Catalyst Pharmaceuticals Inc (CPRX) as of April 8, 2024, with a value of $5 Million and a weighting of 96.26%. David S Tierney owns 25,000 shares of BioPharmX Corp (BPMX) as of September 19, 2018, with a value of $153,000 and a weighting of 2.84%. David S Tierney also owns 10,835 shares of Zevra Therapeutics Inc (ZVRA) as of March 9, 2023, with a value of $48,974 and a weighting of 0.91%.
Latest Holdings of David S Tierney
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2024-04-08 | 348,874 | 14.89 | 5,194,734 |
| BPMX | BioPharmX Corp | 2018-09-19 | 25,000 | 6.12 | 153,000 |
| ZVRA | Zevra Therapeutics Inc | 2023-03-09 | 10,835 | 4.52 | 48,974 |
Holding Weightings of David S Tierney
David S Tierney Form 4 Trading Tracker
According to the SEC Form 4 filings, David S Tierney has made a total of 5 transactions in Catalyst Pharmaceuticals Inc (CPRX) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Catalyst Pharmaceuticals Inc is the sale of 25,000 shares on April 8, 2024, which brought David S Tierney around $392,000.
According to the SEC Form 4 filings, David S Tierney has made a total of 0 transactions in BioPharmX Corp (BPMX) over the past 5 years. The most-recent trade in BioPharmX Corp is the acquisition of 333 shares on September 19, 2018, which cost David S Tierney around $20,000.
According to the SEC Form 4 filings, David S Tierney has made a total of 4 transactions in Zevra Therapeutics Inc (ZVRA) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Zevra Therapeutics Inc is the acquisition of 5,000 shares on March 9, 2023, which cost David S Tierney around $20,750.
Insider Trading History of David S Tierney
- 1
David S Tierney Trading Performance
GuruFocus tracks the stock performance after each of David S Tierney's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David S Tierney is 18.31%. GuruFocus also compares David S Tierney's trading performance to market benchmark return within the same time period. The performance of stocks bought by David S Tierney within 3 months outperforms 5 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David S Tierney's insider trading performs compared to the benchmark.
Performance of David S Tierney
Average Return
8.51%
Outperforming Transactions
60%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5 | 18.31 | -6.23 | 8.51 | 1 | -4.86 |
| Relative Return to S&P 500(%) | 2.04 | 12.85 | -14.55 | -8.88 | -12.65 | -15.7 |
David S Tierney Ownership Network
Ownership Network List of David S Tierney
Ownership Network Relation of David S Tierney
David S Tierney Owned Company Details
What does Zevra Therapeutics Inc do?
Who are the key executives at Zevra Therapeutics Inc?
David S Tierney is the director of Zevra Therapeutics Inc. Other key executives at Zevra Therapeutics Inc include director & President and CEO Neil F. Mcfarlane , VP Fin & Corp Controller R. Laduane Clifton , and CCO & EVP & Bus. Development Joshua Schafer .
Zevra Therapeutics Inc (ZVRA) Insider Trades Summary
Over the past 18 months, David S Tierney made 1 insider transaction in Zevra Therapeutics Inc (ZVRA) with a net purchase of 5,000. Other recent insider transactions involving Zevra Therapeutics Inc (ZVRA) include a net purchase of 6,100 shares made by R. Laduane Clifton , a net purchase of 3,500 shares made by Joshua Schafer , and a net purchase of 1,000 shares made by Watton Corey Michael .
In summary, during the past 3 months, insiders sold 0 shares of Zevra Therapeutics Inc (ZVRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zevra Therapeutics Inc (ZVRA) were sold and 77,819 shares were bought by its insiders, resulting in a net purchase of 77,819 shares.
Zevra Therapeutics Inc (ZVRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zevra Therapeutics Inc Insider Transactions
David S Tierney Mailing Address
Above is the net worth, insider trading, and ownership report for David S Tierney. You might contact David S Tierney via mailing address: C/o Able Laboratories, Inc., 6 Hollywood Court, Cn 1013, South Plainfield Nj 07080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
